Given that ~95% of BGY's portfolio is outside the U.S., that is all very relevant for BGY. However, the fund also employs a ...
Simply Good Foods has seen its price target trimmed to $27, a move that analysts frame as a reset that better matches cooling growth expectations and rising execution risks. Bulls argue the new target ...
Orla Mining's Q3'25 results and strong exploration outlook make it a top gold stock to watch. Read here for an investment ...
On Thursday, December 4, 2025, the Italian daily newspaper Il Giornale published a crushing article exposing Francesca ...
America is about to enter its 250th year, an anniversary set to revive interest in civics and in celebrating U.S. history in ...
Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival ...
Mental health awareness campaigns have become a staple in universities and schools, aiming to reduce stigma and encourage ...
Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk ...
The return of Joe Musgrove will be huge for the 2026 San Diego Padres. The Padres need pitching and Musgrove is a name that ...
QuinStreet’s latest narrative update keeps its fair value steady at $21.75 per share, even as analysts refine their assumptions around risk and growth. A slightly lower discount rate and a modest ...
The New York Festivals Radio Awards provides a platform to celebrate creative storytellers from around the world. For 69 ...
New two- and three-year EPCORE® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in patients with DLBCL and FLLatest EPCORE DLBCL-3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results